ENHERTU 100MG INJECTION

Most patients can maintain their normal activities while on ENHERTU 100MG INJECTION. However, you should monitor how you feel closely. Side effects like fatigue, nausea, or other symptoms might necessitate adjustments to your daily routine. Always consult your healthcare provider for personalized advice based on your situation.

ENHERTU 100MG INJECTION may have an impact on fertility. If you are planning to have children in the future, it's crucial to discuss this with your healthcare provider before starting treatment. They may suggest fertility preservation options and provide guidance tailored to your personal and family plans.

While on ENHERTU 100MG INJECTION, managing nausea and vomiting is important, and your oncology care team can provide medications to help with these symptoms. Additionally, making changes to your diet can be beneficial. It's advisable to avoid foods that could aggravate these symptoms, such as heavy, greasy, or fatty foods and spicy or acidic items like lemons, tomatoes, and oranges.

Based on the findings from four major studies, the standard treatment for patients with HER2-positive early breast cancer involves taking adjuvant ENHERTU 100MG INJECTION for one year alongside chemotherapy. This approach has become the established method of care following these significant trials.

The success of ENHERTU 100MG INJECTION in treating breast cancer is significant. Clinical studies have shown that the five-year invasive breast cancer-free survival rate is 97.4% among patients treated with trastuzumab.

It is important to inform your doctor about all medications, supplements, and herbal products you are currently taking to check for potential interactions with ENHERTU 100MG INJECTION.

If you are taking ENHERTU 100MG INJECTION, it is crucial to regularly monitor your lung and liver functions with your doctor due to potential side effects.

Both women and men should use effective contraception during treatment with ENHERTU 100MG INJECTION. Women should continue using birth control for at least seven months after the final dose, while men should do so for four months after completing treatment to avoid risks to their partners who may become pregnant. Additionally, male patients should discuss sperm preservation options with their doctor before starting the medication as it may impact fertility.

ENHERTU 100MG INJECTION contains the active molecule/combination called TRASTUZUMAB DERUXTECAN.

ENHERTU 100MG INJECTION is prescribed for the treatment of certain types of cancers, as determined by your healthcare provider.

ENHERTU 100MG INJECTION is an anti-cancer medication that works by targeting specific cancer cells to slow down or stop their growth. Your doctor can explain the specific mechanism relevant to your condition.